Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Since hypercoagulability might result in recurrent miscarriage, anticoagulant agents could potentially increase the live-birth rate in subsequent pregnancies in women with either inherited thrombophilia or unexplained recurrent miscarriage. OBJECTIVES: To evaluate the efficacy and safety of anticoagulant agents, such as aspirin and heparin, in women with a history of at least two miscarriages without apparent causes other than inherited thrombophilia. SEARCH STRATEGY: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (April 2008), the Cochrane Central Register of Controlled Trials (The Cochrane Library 2007, Issue 1), MEDLINE (January 1966 to March 2007), and EMBASE (1980 to March 2007). We scanned bibliographies of all located articles for any unidentified articles. SELECTION CRITERIA: Randomised and quasi-randomised controlled trials that assessed the effect of anticoagulant treatment on the live-birth rate in women with a history of at least two miscarriages (up to 20 weeks of amenorrhoea) without apparent causes other than inherited thrombophilia were eligible. Interventions included aspirin, unfractionated heparin, and low molecular weight heparin for the prevention of miscarriage. One treatment could be compared with another or with placebo. DATA COLLECTION AND ANALYSIS: Two authors assessed the trials for inclusion in the review and extracted the data. We double checked the data. MAIN RESULTS: Two studies (189 participants) were included in the review. In one study, 54 pregnant women with recurrent miscarriage (RM) but no detectable anticardiolipin antibodies were randomised to low-dose aspirin or placebo. RM was defined as three or more consecutive miscarriages (occurring before 22 weeks' gestational age (based on last menstrual period)). Similar live-birth rates were observed with aspirin and placebo, both 81% (risk ratio (RR) 1.00, 95% confidence interval (CI) 0.78 to 1.29). In the other study, 107 women with consecutive recurrent miscarriage without any apparent cause and no hereditary thrombophilia were randomised between enoxaparin and aspirin. Here RM was stated as three or more consecutive first trimester miscarriages or at least two consecutive second trimester miscarriages. Similar live birth rates were observed with enoxaparin and aspirin, respectively 82% and 84% (RR 0.97, 95% CI 0.81 to 1.16). AUTHORS' CONCLUSIONS: There is a paucity in studies on the efficacy and safety of aspirin and heparin in women with a history of at least two miscarriages without apparent causes other than inherited thrombophilia. The two reviewed trials studied different treatments and only one study was placebo-controlled. Neither of the studies showed a benefit of one treatment over the other. Therefore, the use of anticoagulants in this setting is not recommended. However, large randomised placebo-controlled trials are still urgently needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rai, R., Cohen, H., Dave, M., & Regan, L. (1997) · BMJ · doi:10.1136/bmj.314.7076.253 · Cited by 1,113
Thrombophilic disorders and fetal loss: a meta-analysis
Rey, E., Kahn, S. R., David, M., & Shrier, I. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12771-7 · Cited by 872
Increased fetal loss in women with heritable thrombophilia
Preston, F., Rosendaal, F., Walker, I., Briët, E., Berntorp, E., Conard, J., Fontcuberta, J., Makris, M., Mariani, G., Noteboom, W., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)04125-6 · Cited by 661
Recurrent miscarriage I: definition and epidemiology
Stirrat, G. M. (1990) · The Lancet · doi:10.1016/0140-6736(90)92159-f · Cited by 600
Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant
Empson, M. B., Lassere, M., Craig, J. C., & Scott, J. R. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002859.pub2 · Cited by 486
Gris, J.-C., Mercier, E., Quéré, I., Lavigne-Lissalde, G., Cochery-Nouvellon, E., Hoffet, M., Ripart-Neveu, S., Tailland, M.-L., Dauzat, M., & Marès, P. (2004) · Blood · doi:10.1182/blood-2003-12-4250 · Cited by 397
Immunotherapy for recurrent miscarriage
Wong, L. F., Porter, T. F., & Scott, J. R. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000112.pub3 · Cited by 348
Cytogenetic studies in couples experiencing repeated pregnancy losses
Braekeleer, M. D., & Dao, T.-N. (1990) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a137135 · Cited by 272
Rai, R. S., Regan, L., Clifford, K., Pickering, W., Dave, M., Mackie, I., McNally, T., & Cohen, H. (1995) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a136224 · Cited by 238
Cited by
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
Bates, S. M., Greer, I. A., Middeldorp, S., Veenstra, D. L., Prabulos, A.-M., & Vandvik, P. O. (2012) · Chest · doi:10.1378/chest.11-2300 · Cited by 1,525
Self-citationAspirin Plus Heparin or Aspirin Alone in Women With Recurrent Miscarriage
Kaandorp, S. P., Goddijn, M., van der Post, J. A. M., Hutten, B. A., Verhoeve, H. R., Hamulyák, K., Willem Mol, B., Folkeringa, N., Nahuis, M., Papatsonis, D. N. M., et al. (2010) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e3182021f71 · Cited by 364
Self-citationSOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014
Lowe, S. A., Bowyer, L., Lust, K., McMahon, L. P., Morton, M., North, R. A., Paech, M., & Said, J. M. (2015) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12399 · Cited by 299
Recurrent miscarriage: causes, evaluation and management
Garrido-Gimenez, C., & Alijotas-Reig, J. (2015) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2014-132672 · Cited by 270
de Jong, P. G., Kaandorp, S., Di Nisio, M., Goddijn, M., & Middeldorp, S. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004734.pub4 · Cited by 204
Self-citation
Metadata
- Authors
- Kaandorp, S., Di Nisio, M., Goddijn, M., & Middeldorp, S.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- John Wiley & Sons, Ltd
- Published
- 2009-01-21
- Issue
- 1
- Pages
- CD004734-CD004734
- ISSN
- 1361-6137 (ISSN-L)
- OpenAlex
- W2162670607
- Cited by
- 115
- References
- 9
- Type
- reference entry
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.